Kyle Mcintyre Email & Phone Number

Huntsville, Al, Us

● Design custom global projects, evaluating site selection, targeted diseases, and data analysis. Build protocols to mitigate risk, incorporating local IRB, GDPR, and stakeholders.

Huntsville, Alabama, United States

● Hired and trained 10 feasibility staff members for team expansion goals; integrated European staff into the global feasibility structure to consolidate the global network● Produced quality and regulatory frameworks to ensure adherence to GMP guidelines and site regulations● Reduced feasibility response turnaround time by 54%, from 7.3 to 3.4 business days ● Developed site acquisition strategies incorporating competing clinical trial landscape including barriers to enrollment, prevalence of disease, data collection protocols and analysis, and varied location distribution ● Led team that evaluates ~3,700 cases valued at 45% of potential company revenue● Created a cost, site selection, and project implementation database to share cost analysis among operational divisions ● Increased communications with the Logistics Department to evaluate vendors and estimate the shipping time and costs for challenges presented post-pandemic● Collaborated with the project management team to identify the root cause of problems and generate recommendations to improve study execution and remove patient enrollment roadblocks● Developed risk mitigation and budget strategies and optimized ongoing trials to adhere to local IRB and GDPR● Guided clinical affairs team and KOLs on-site identification efforts to align with feasibility requests and product strategy

● Hired and trained feasibility staff members● Spearheaded and implemented cross-functional data-driven processes to consolidate inquiries across business units ● Trained M&A sales, operations, and feasibility teams on established feasibility processes and optimized protocol design● Assessed projects complying with local Standard of Care treatment, provided consultation, and delivered presentations● Led team that evaluated ~2,800 cases per year valued at ~37% of potential company revenue● Responsible for issuing Purchase Orders to maintain stock levels for all Blood and Cell Services products as well as any further characterization needed via genomic or IHC● Guided clinical affairs team on-site identification efforts to align with feasibility requests and product strategy● Gathered competitive intelligence data for market research analysis from conception to product launch for the following which are expected to encompass ~38% biospecimen revenue: FFPE & Matched DSP Plasma (Characterized), DTCs (Characterized), Targeted Plasma/PBMCs/Serum, Fresh & Cryo RUO Leukopaks, Designed Custom NGS SpecimenSEQ Panel with QCI report for all Tissues, COVID-19 Inventory, Cell Services Speciality Lab

Huntsville, Alabama Area

● Responsible for evaluating, pricing, and providing alternative solutions for the company's prospectivepipeline● Applied clinical knowledge to improve protocols incorporating therapeutic area limitations and site capabilities ● Increased engagement level with clients to allow for a consultative approach for project design● Attended AACR and IO Summit to increase awareness of trends in research● Evaluated ~1,500 feasibility cases per year with an estimated value at ~42% of potential company revenue

Huntsville, Alabama Area

● Hired and trained clinical research team● Optimized research schedule to maximize potential targets for client collections and high-value inventory● Trained histopathology team on staging based on AJCC guidelines from archival pathology reports● Increased efficiency by creating a solution to customize client data manifests

● Researched and targeted patient collections based on client-specific inclusion and exclusion criteria● Prepared project-specific data for client orders● Provided insight into company-wide capabilities for potential future projects● Implemented change that improved collection rates● Co-led effort to transition research into the company CRM